相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Societal Value of Broader Access to Antiobesity Medications
Mina Kabiri et al.
OBESITY (2020)
Lifetime benefits of early detection and treatment of diabetic kidney disease
Julia Thornton Snider et al.
PLOS ONE (2019)
Ten-year Medicare budget impact of increased coverage for anti-obesity intervention
Fang Chen et al.
JOURNAL OF MEDICAL ECONOMICS (2019)
Projected US State-Level Prevalence of Adult Obesity and Severe Obesity
Zachary J. Ward et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity
G. Gomez et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Patrick M. O'Neil et al.
LANCET (2018)
Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum-Sensitive Recurrent Ovarian Cancer
Lixian Zhong et al.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2018)
A cost-benefit analysis of smoking cessation prescription coverage from a US payer perspective
Christine L. Baker et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2018)
Utilization of smoking cessation medication benefits among medicaid fee-for-service enrollees 1999-2008
Jennifer Kahende et al.
PLOS ONE (2017)
Productivity loss due to overweight and obesity: a systematic review of indirect costs
Andrea Goettler et al.
BMJ OPEN (2017)
Provider attitudes and practice patterns of obesity management with pharmacotherapy
Brittany Granara et al.
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Trends in Use of Medications for Smoking Cessation in Medicare, 2007-2012
Marian Jarlenski et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2016)
Severe Obesity In Adults Cost State Medicaid Programs Nearly $8 Billion In 2013
Y. Claire Wang et al.
HEALTH AFFAIRS (2015)
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial
Melanie J. Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Treatment of obesity: Pharmacotherapy trends in the United States from 1999 to 2010
Ying Xia et al.
OBESITY (2015)
The Effect of Obesity and Chronic Conditions on Medicare Spending, 1987-2011
Lindsay Allen et al.
PHARMACOECONOMICS (2015)
The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011
Kenneth E. Thorpe et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2015)
Prevalence of Childhood and Adult Obesity in the United States, 2011-2012
Cynthia L. Ogden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Economic costs of overweight and obesity
Thomas Lehnert et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study
T. A. Wadden et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
Myths, Presumptions, and Facts about Obesity
Krista Casazza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II)
Caroline M. Apovian et al.
OBESITY (2013)
Use of Prescription Antiobesity Drugs in the United States
Christian Hampp et al.
PHARMACOTHERAPY (2013)
The impact of weight loss among seniors on Medicare spending
Kenneth E. Thorpe et al.
HEALTH ECONOMICS REVIEW (2013)
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
W. Timothy Garvey et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Management of Obesity in the National Health and Nutrition Examination Survey (NHANES), 2007-2008
Nithushi R. Samaranayake et al.
ANNALS OF EPIDEMIOLOGY (2012)
Cigarette Taxes and the Federal Budget - Report from the CBO
James R. Baumgardner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Kishore M. Gadde et al.
LANCET (2011)
Long-term Health and Economic Impact of Preventing and Reducing Overweight and Obesity in Adolescence
Li Y. Wang et al.
JOURNAL OF ADOLESCENT HEALTH (2010)
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management.
Steven R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The economic impact of obesity in the United States
Ross A. Hammond et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2010)
THE FISCAL CONSEQUENCES OF TRENDS IN POPULATION HEALTH
Dana Goldman et al.
NATIONAL TAX JOURNAL (2010)
The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older
Dana P. Goldman et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2009)
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
G. A. Bray et al.
LANCET (2009)
Population-based analysis of obesity and workforce participation
Scott Klarenbach et al.
OBESITY (2006)
Lost productive time associated with excess weight in the US workforce
JA Ricci et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2005)
Efficacy of lifestyle modification for long-term weight control
TA Wadden et al.
OBESITY RESEARCH (2004)
Medical consequences of obesity
GA Bray
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
分享论文
